How Unfair Sanctions have Impacts on Iranian Patients?

Wednesday, January 1, 2020 - 16:39

While many people all across the world are celebrating the end of the decade, many Iranian people with serious illnesses have been put at imminent risk of international sanction.

According to an ISCA report, while people have been gathering to ring in the 2020 New Year with fireworks and musical celebrations all across the world, U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer and epilepsy.

The US sanctions and restrictions on export of drugs and medical equipment to Iran have shortened the breath of patients suffering from cancer, hemophilia, epilepsy and thalassemia.

In a Foreign Policy article earlier this year, Dr. Abbas Kebriaee Zadeh, professor of toxicology and pharmacology at Tehran University of Medical Sciences, wrote that US sanctions against Iran indirectly hamper the flow of vital medicines for cancer patients in the Islamic Republic, Fars News Agency reports.

“The article revealed that while Washington claims its harsh sanctions against Iran would not target the flow of medicine and other humanitarian necessities into Iran, banking sanctions are in fact increasing import prices, blocking supply chains, and creating deadly drug shortages in the country.”

Meantime, early in December, Head of Iran's Food and Drug Administration (IFDA) and Deputy Health Minister Mohammadreza Shanehsaz said that Washington's sanctions and the recent warning issued by the US Treasury Department was meant to be a coup against the Iranian patients, particularly those with special needs.

"The drugs for the MPS patients were due to be supplied by the American company which produces the medicine but the US has directly sanctioned the Iranian MPS patients and they did not export it to us," Spokesman for Iran's Food and Drug Administration Kianoush Jahanpour wrote on his twitter page.

Despite the American officials' claims of not imposing sanctions on imports of drugs to Iran, it is reported that medications are hard to obtain in the country due to banking embargos that hamper money transactions which causes some Western companies to refuse to sell the necessary drugs and medical equipment to Tehran.


Popular News

Latest News